Molecular Partners Ag MOLN
NASDAQ MOLN
$4.18 -0.17 (-3.76%)
As of: Sep 10, 2026 · 9:51 AM EDT

Molecular Partners Ag (MOLN) Prepaid Assets (2020 - 2026)

Molecular Partners Ag's (MOLN) quarterly Prepaid Assets came in at $2.7 million in Q2 2026, down 8.54% year-over-year from $3.0 million in Q2 2025, and up 15.92% quarter-over-quarter from $2.4 million in Q1 2026.

Analysis

Molecular Partners Ag (MOLN) Prepaid Assets (2020 - 2026) Analysis & Trends

Molecular Partners Ag (MOLN) has reported Prepaid Assets for 7 consecutive years, with $2.7 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Prepaid Assets fell 8.54% year-over-year to $2.7 million in Q2 2026; TTM through Jun 2026 was $2.7 million, a 8.54% decrease from a year earlier, with the FY2025 full-year figure at $2.4 million, down 16.58% from the prior year.
  • Prepaid Assets was $2.7 million for Q2 2026 at Molecular Partners Ag, up from $2.4 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $5.0 million in Q3 2022 and troughed at $2.3 million in Q1 2025.
  • A 5-year average of $3.5 million and a median of $3.3 million in 2024 frame the typical range for Prepaid Assets.
  • Across the five-year window, Prepaid Assets sank 41.32% in 2022 and grew 2.49% in 2026, its largest moves.
  • Over 5 years, Prepaid Assets stood at $4.8 million in 2022, then decreased by 14.4% to $4.1 million in 2023, then fell by 29.31% to $2.9 million in 2024, then dropped by 13.83% to $2.5 million in 2025, then grew by 10.09% to $2.7 million in 2026.
  • The last three Prepaid Assets figures came in at $2.7 million (Q2 2026), $2.4 million (Q1 2026), and $2.5 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Molecular Partners Ag 156.54 Mn 156.54 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.73 Mn
Mar 31, 2026 2.36 Mn
Dec 31, 2025 2.48 Mn
Sep 30, 2025 2.92 Mn
Jun 30, 2025 2.99 Mn
Mar 31, 2025 2.30 Mn
Dec 31, 2024 2.88 Mn
Sep 30, 2024 3.00 Mn
Jun 30, 2024 3.44 Mn
Mar 31, 2024 3.29 Mn
Dec 31, 2023 4.08 Mn
Sep 30, 2023 3.99 Mn
Jun 30, 2023 4.62 Mn
Mar 31, 2023 3.64 Mn
Dec 31, 2022 4.76 Mn
Sep 30, 2022 5.00 Mn
Mar 31, 2022 4.21 Mn
Dec 31, 2021 6.21 Mn
Sep 30, 2021 8.51 Mn
Dec 31, 2020 1.39 Mn